Pharmacological compounds that release nitric oxide (NO) have been useful tools for
evaluating the broad role of NO in physiology and therapeutics. NO deficiency has been …

The biologically important gaseous radical, nitric oxide (NO), is a versatile chemical entity
that enters into regulatory, protective, and adverse interactions with biomolecules and cells …

Nitric oxide (NO) mediates multiple physiological and pathophysiological processes in the
cardiovascular system. Pharmacological compounds that release NO have been useful tools …

The discovery of the multiple physiological and pathophysiological processes in which nitric
oxide (NO) is involved has promoted a great number of pharmacological researches to …

Research over the past 20 years has identified endogenous nitric oxide (NO) as a key
messenger molecule in the cardiovascular, nervous and immune systems. Research to date …

In retrospect, basic research in the fields of NO and cyclic GMP during thev past two
decades appears to have followed a logical course beginning with the findings that NO and …

Nitric oxide is becoming an increasingly important signalling molecule implicated in a
growing number of physiological and pathophysiological processes. Moreover, with the …

The goal of nitric oxide (NO) based pharmacotherapy is to reach proper homeostasis of NO
metabolism in the target tissue where endogenous production of NO is either too weak or …

During the last decade, a multitude of experimental arguments have led to the concept that
EDRF is nitric oxide (NO), a messenger not only involved in the control of vasomotor tone …

During the 1980s, the free radical, nitric oxide (NO), was discovered to be a crucial
signalling molecule, with wide‐ranging functions in the cardiovascular, nervous and immune …